deoxycytidine and Benign Fibrous Mesothelioma

deoxycytidine has been researched along with Benign Fibrous Mesothelioma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chapel, DB; Husain, AN; Krausz, T	1
Fukuoka, J; Hori, T; Hosokawa, A; Ishizawa, S; Kitano, H; Kudo, T; Kuroda, K; Sugiyama, T; Tanaka, T; Tsukada, K; Uotani, H	1

Other Studies

2 other study(ies) available for deoxycytidine and Benign Fibrous Mesothelioma

Article	Year
Immunohistochemical evaluation of nuclear 5-hydroxymethylcytosine (5-hmC) accurately distinguishes malignant pleural mesothelioma from benign mesothelial proliferations. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2019, Volume: 32, Issue:3 Topics: Biomarkers, Tumor; Deoxycytidine; Diagnosis, Differential; Humans; Immunohistochemistry; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Pleural Neoplasms; Sensitivity and Specificity; Solitary Fibrous Tumor, Pleural; Tumor Suppressor Proteins; Ubiquitin Thiolesterase	2019
Localized malignant mesenteric mesothelioma causing small bowel obstruction. Pathology international, 2008, Volume: 58, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Disease-Free Survival; Endoscopy, Gastrointestinal; Epithelioid Cells; Gemcitabine; Humans; Intestinal Obstruction; Male; Mesentery; Middle Aged; Peritoneal Neoplasms; Solitary Fibrous Tumor, Pleural; Treatment Outcome	2008

Article

Year

Immunohistochemical evaluation of nuclear 5-hydroxymethylcytosine (5-hmC) accurately distinguishes malignant pleural mesothelioma from benign mesothelial proliferations.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2019, Volume: 32, Issue:3

Topics: Biomarkers, Tumor; Deoxycytidine; Diagnosis, Differential; Humans; Immunohistochemistry; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Pleural Neoplasms; Sensitivity and Specificity; Solitary Fibrous Tumor, Pleural; Tumor Suppressor Proteins; Ubiquitin Thiolesterase

2019

Localized malignant mesenteric mesothelioma causing small bowel obstruction.

Pathology international, 2008, Volume: 58, Issue:4

Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Disease-Free Survival; Endoscopy, Gastrointestinal; Epithelioid Cells; Gemcitabine; Humans; Intestinal Obstruction; Male; Mesentery; Middle Aged; Peritoneal Neoplasms; Solitary Fibrous Tumor, Pleural; Treatment Outcome

2008